IL17A and type 1 diabetes mellitus: Clinical studies show that T1D patients exhibit significantly higher peripheral levels of GM-CSF+ Th cells compared to healthy controls, correlating positively with plasma IL-17A, IFN-γ, and IL-2 levels 33, 110.